Breaking News

Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business

Broadens Thermo Fisher’s capabilities in the development and manufacturing of biologics, spanning upstream and downstream workflows.

Author Image

By: Charlie Sternberg

Associate Editor

Thermo Fisher Scientific Inc. has entered into a definitive agreement to acquire Solventum’s Purification & Filtration business for approximately $4.1 billion in cash. Solventum’s purification and filtration technologies are used in the production of biologics as well as in medical technologies and industrial applications. The Solventum business operates globally with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, and has approximately 2,500 colle...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters